VivoPower’s Tembo Achieves Key Business Combination Milestone for Nasdaq Listing: Submission of F-4 Registration to SEC on Confidential Basis as Revenue and Global Delivery ...

Target closing date in March 2026, subject to SEC and Nasdaq review and approvalBecoming a publicly listed company on Nasdaq provides Tembo with ...
Crowdfund Insider

SEC Charges Crypto Trading Platforms and Investment Clubs with Scheme Targeting Retail Investors via Social Media

The Securities and Exchange Commission recently filed charges against purported crypto asset trading platforms Morocoin Tech Corp., others.

Tale of the Tape: The SEC’s ‘Notice First’ Approach to Technical Violations

Jonathan Sabin and Peter Herman analyze the SEC's September 2025 policy shift under Chairman Paul Atkins toward a "notice ...

Social Commerce Partners Corporation Announces Closing of $100,000,000 Initial Public Offering

Social Commerce Partners Corporation (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the closing of its initial ...

Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis

Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Paris, December 24, 2025. The US Food and Drug Administration (FDA) has issued a ...

SEC Targets Crypto Platforms in Social Media Scam Crackdown

The Securities and Exchange Commission launched an enforcement wave targeting three purported cryptocurrency trading ...

Akari Therapeutics Initiates GMP Manufacturing of AKTX-101 ADC Program to Support Phase 1 First-in-Human Clinical Trial

Akari Will Exclusively Partner With Industry Leader WuXi XDC For This Key IND-enabling WorkTAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology ...